$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
Oncology
Oncology
Oncology_Medical Halo Global Medical Oncology News_Oncology Drug Therapy News
美国肿瘤内科医生分享结肠癌治疗经验
2025-10-19 11:44:20
Check Details
结直肠癌的病因有哪些?
2025-10-19 11:44:20
Check Details
瑞格非尼耐受性的真实世界研究数据
2025-10-19 11:44:20
Check Details
瑞格菲尼治疗肠癌的用量如何调整?
2025-10-19 11:44:20
Check Details
瑞格菲尼改写了晚期肝癌的靶向药物选择范围
2025-10-19 11:44:20
Check Details
CFDA批准的瑞格非尼主要的适应症有哪些?
2025-10-19 11:44:20
Check Details
瑞格非尼服用时应注意哪些事项?
2025-10-19 11:44:20
Check Details
瑞格非尼治疗结直肠癌的推荐剂量
2025-10-19 11:44:20
Check Details
瑞戈非尼延长转移性结直肠癌患者的无进展生存期
2025-10-19 11:44:20
Check Details
瑞格非尼对不同临床特征患者的有效性
2025-10-19 11:44:20
Check Details
瑞格非尼如何服用?
2025-10-19 11:44:20
Check Details
尼拉帕尼可增强伊立替康对结直肠癌的疗效
2025-10-19 11:44:20
Check Details
1
2
...
1582
1583
1584
1585
1586
1587
1588
...
4150
4151
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Ceritinib Capsule Storage Conditions & Expiration Guide: Room Temperature Storage, No Refrigeration Needed
2
Selumetinib for NF1 Treatment: Complete Guide to Targeted Therapy for Type 1 Neurofibromatosis
3
Alectinib for ALK-Positive Lung Cancer: Efficacy, Side Effects & Clinical Outlook
4
Which Generation TKI Is Repotrectinib? Professional Analysis of Next-Gen ROS1 Inhibitor Classification and Clinical Features
5
Dietary Guide During Goserelin Treatment: Scientific Nutrition Management to Alleviate Side Effects and Improve Quality of Life.
6
CYP26A1 Gene Emerges as New Target for Colorectal Cancer Treatment! Folate Metabolism Research Brings Hope for Immunotherapy.
7
Precision Breakthrough: Inavolisib Redefines Survival in PIK3CA-Mutant Breast Cancer
8
Optimal Regorafenib (Stivarga) Administration Guide: Low-Fat Diet, Fixed Timing, and Dose Escalation Strategies
9
Guidelines for the timing, method, and precautions of taking Erlotinib (Trokai).
10
Important Information for Safe Use of Ibrutinib
11
Comprehensive description of palbociclib
12
Pralsetinib: The RET Precision-Targeted Therapy That Rewrites the Treatment History of Rare Cancers